Julex Capital Management’s Usana Health Sciences USNA Stock Holding History

Julex Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$2K	Buy	+26	New	+$1.75K	﹤0.01%	138

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Julex Capital Management's USNA Position: Q3 2019 in Review

Julex Capital Management opened a new position in Usana Health Sciences (USNA) in Q3 2019: 26 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #138 among its holdings.

169 funds tracked by Wall St. Rank hold USNA as of Q3 2019.

Julex Capital Management held 26 shares of Usana Health Sciences worth $2K as of Q3 2019.
Usana Health Sciences was a new Julex Capital Management position in Q3 2019.
Usana Health Sciences made up ﹤0.01% of Julex Capital Management's portfolio in Q3 2019, its #138 holding.
169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2019.

Based on Julex Capital Management's 13F filing for Q3 2019, filed 18 Oct 2019.